HCPLive Network

Even Correctly Administered NSAIDs Can Cause Acute Kidney Injury in Kids

TUESDAY, Jan. 29 (HealthDay News) -- Nonsteroidal anti-inflammatory drug (NSAID)-associated acute kidney injury (AKI) accounts for almost 3 percent of pediatric AKI, according to a study published online Jan. 28 in The Journal of Pediatrics.

Jason M. Misurac, M.D., from Indiana University in Indianapolis, and colleagues retrospectively reviewed the charts of 1,015 children with a diagnosis of AKI to characterize NSAID-linked AKI. A diagnosis explaining AKI or comorbid clinical conditions predisposing to AKI development negated a classification of NSAID-associated AKI.

The researchers found that 21 children had clinical, laboratory, and radiographic studies suggesting NSAID-associated acute tubular necrosis and six had findings suggesting NSAID-associated acute interstitial nephritis, representing 2.7 percent of the total cohort with AKI. The median age for children with NSAID-associated AKI was 14.7 years and four patients were younger than 5 years. Of the 20 children for whom dosing data were available, 75 percent received NSAIDs within recommended dosing limits. Dialysis, intensive care unit admission, and longer length of stays were significantly more likely in children younger than 5 years of age.

"NSAID-associated AKI accounted for 2.7 percent of AKI in this pediatric population," the authors write. "AKI typically occurred after the administration of correctly dosed NSAIDs. Young children with NSAID-associated AKI may have increased disease severity."

Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Use of triple therapy comprising diuretics and angiotensin converting enzyme inhibitors, or angiotensin receptor blockers, together with nonsteroidal anti-inflammatory drugs is associated with an increased risk of acute kidney injury, particularly in the first 30 days of treatment, according to a study published online Jan. 8 in BMJ.
Results from a recent study show that intensive statin therapy in patients with acute coronary syndrome does not increase the risk of kidney injury.
A recent study suggests that dialysis patients' use of opioid analgesics (OAs) is widespread and exceeding historical limits, and that the patients who use opioids are staying on them longer.
According to the authors of a recent study, almost 50% of patients with end-stage renal disease (ESRD) say they have chronic pain, and over 75% of them rate it as being moderate to severe.
Acute kidney injury is seen in about 7 percent of patients undergoing percutaneous coronary intervention and is associated with significant in-hospital mortality, according to research published in the Jan. 1 issue of the Journal of the American College of Cardiology: Cardiovascular Interventions.
Traditional NSAIDs and second-generation NSAIDs (cyclooxygenase-2 inhibitors) are commonly prescribed treatments for a wide range of painful conditions, including acute pain, low back pain, headache, rheumatoid arthritis, and osteoarthritis. However, these medications are also associated with serious gastrointestinal complications and other adverse events.
Pain beginning at delivery is rarely reported six to 12 months after delivery; and the postpartum period seems to protect from chronic hypersensitivity to peripheral nerve injury in rats, according to two studies published in the January issue of Anesthesiology.
More Reading